Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver

Clin Colorectal Cancer. 2018 Mar;17(1):e45-e48. doi: 10.1016/j.clcc.2017.09.005. Epub 2017 Sep 28.

¹ Department of Internal Medicine, Gunmaken Saiekikai Maebashi Hospital, Maebashi, Japan; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
² Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
³ Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Maebashi, Japan.
⁴ Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
⁵ Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
⁶ Department of Endoscopy and Endoscopic Surgery, Gunma University Hospital, Maebashi, Japan.
⁷ Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Maebashi, Japan. Electronic address: okadash@gunma-u.ac.jp.

No abstract available

Keywords: Carcinoembryonic antigen; Cetuximab; Colon cancer; Diabetes mellitus; SGLT2 inhibitor.

Publication types